More and more cancer treatments are being delivered outside the health care setting. When it's within the hospital setting, the medications are covered, but when we have take-home medications, particularly those that are the supportive medications that improve quality of life, those are covered by drug plans or the patient pays out of pocket.
When we look at it through an equity lens, women are less likely to have those health benefit plans, and they're also less likely to have that cash in their pocket. It really is about who is being hurt the most when there isn't a pharmacare policy. It would improve access for all people and improve their ability to be treated for and survive cancer if they didn't have the stress related to access.